Legend Biotech (LEGN) Other Accumulated Expenses (2023 - 2026)

Legend Biotech (LEGN) has 2 years of Other Accumulated Expenses data on file, last reported at $1.0 million in Q4 2025.

• Quarterly Other Accumulated Expenses rose 100.0% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 100.0% YoY) and the FY2025 annual result came in at $1.0 million, up 100.0% from the prior year.
• Other Accumulated Expenses held at $1.0 million in Q4 2025, from $1.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.0 million in Q3 2025 to a low of $500000.0 in Q4 2024.